Calcidia



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 22.2%
Hypocalcaemia 22.2%
Diuretic Therapy 11.1%
Gastric Ulcer 11.1%
Lung Disorder 11.1%
Pain 11.1%
Urinary Tract Infection 11.1%
Pancytopenia 50.0%
Vomiting 50.0%
Secondary
Product Used For Unknown Indication 37.3%
Drug Use For Unknown Indication 25.9%
Haemolytic Uraemic Syndrome 10.4%
Hypertension 5.2%
Dialysis 3.1%
Rheumatoid Arthritis 3.1%
Diabetes Mellitus 2.1%
Arrhythmia Supraventricular 1.6%
Palpitations 1.6%
Atrial Fibrillation 1.0%
Diuretic Therapy 1.0%
Gastric Ulcer 1.0%
Hyperphosphataemia 1.0%
Hypocalcaemia 1.0%
Immunisation 1.0%
Pain 1.0%
Polyuria 1.0%
Essential Hypertension 0.5%
Peritoneal Dialysis 0.5%
Renal Failure Chronic 0.5%
Rash Erythematous 14.8%
Thrombocytopenia 14.8%
Cardio-respiratory Arrest 11.1%
Hypertension 7.4%
Melanosis Coli 7.4%
Pancytopenia 7.4%
Drug Interaction 3.7%
Eosinophilia 3.7%
Hypoglycaemia 3.7%
Hypoxic-ischaemic Encephalopathy 3.7%
Jaundice 3.7%
Sepsis 3.7%
Splenomegaly 3.7%
Tooth Infection 3.7%
Toxic Skin Eruption 3.7%
Vomiting 3.7%
Concomitant
Drug Use For Unknown Indication 39.3%
Product Used For Unknown Indication 19.0%
Renal Transplant 9.9%
Multiple Myeloma 3.8%
Transplant Rejection 3.6%
Hypertension 3.1%
Peritoneal Dialysis 2.8%
Prophylaxis 1.8%
Tuberculosis 1.8%
Coronary Arterial Stent Insertion 1.7%
Peritonitis Sclerosing 1.7%
Hepatitis C 1.5%
Prophylaxis Against Transplant Rejection 1.5%
Dialysis 1.3%
Renal Failure 1.3%
Rheumatoid Arthritis 1.3%
Anaemia 1.2%
Diabetes Mellitus 1.2%
Pain 1.2%
Glomerulonephritis 1.0%
Aplastic Anaemia 10.5%
Toxic Skin Eruption 9.3%
International Normalised Ratio Increased 8.1%
Renal Failure Acute 7.0%
Cholestasis 5.8%
Malaise 5.8%
Tachycardia 5.8%
Wound Dehiscence 5.8%
Peritonitis Sclerosing 4.7%
Pyrexia 4.7%
Vomiting 4.7%
Lung Disorder 3.5%
Peritoneal Cloudy Effluent 3.5%
Pulmonary Embolism 3.5%
Respiratory Distress 3.5%
Somnolence 3.5%
Thrombocytopenia 3.5%
Anaphylactic Shock 2.3%
Anastomotic Haemorrhage 2.3%
Cardiac Arrest 2.3%